Regulatory T cells under scrutiny

Nature Reviews Immunology

Volumn 3, Issue 3, 2003, Pages 189-198

  Bach, Jean François ^a  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; INTERLEUKIN 2 RECEPTOR; CYTOKINE;

ANTIGEN SPECIFICITY; CELL ACTIVITY; CELL SPECIFICITY; IMMUNE RESPONSE; IMMUNOPATHOLOGY; IMMUNOREGULATION; ONTOGENY; PHENOTYPE; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE; ANIMAL; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; INNATE IMMUNITY; LYMPHOCYTE SUBPOPULATION; REGULATORY T LYMPHOCYTE; SPECIES DIFFERENCE;

ANIMALS; ANTIGENS, CD4; CYTOKINES; HUMANS; IMMUNE TOLERANCE; IMMUNITY, NATURAL; LYMPHOCYTE SUBSETS; RECEPTORS, INTERLEUKIN-2; SPECIES SPECIFICITY; T-LYMPHOCYTES, REGULATORY;

EID: 0142250482     PISSN: 14741733     EISSN: None     Source Type: Journal    
DOI: 10.1038/nri1026     Document Type: Review

References (113)

1. Gershon, R. K. & Kondo, K. Cell interactions in the induction of tolerance: the role of thymic lymphocytes. Immunology 18, 723-737 (1970). The first article to show that T cells can suppress immune responses in an antigen-specific manner.
2. Moller, G. Do suppressor T cells exist? Scand. J. Immunol. 27, 247-250 (1988).
3. Shanmugam, A. et al. Healthy monozygous twins do not recognize identical T-cell epitopes on the myelin basic protein autoantigen. Eur. J. Immunol. 24, 2299-2303 (1994).
4. Bach, J. M. et al High-affinity presentation of an autoantigenic peptide in type 1 diabetes by an HLA class II protein encoded in a haplotype protecting from disease. J. Autoimmun. 10, 375-386 (1997).
5. Ohashi, P. S. et al. Ablation of 'tolerance' and induction of diabetes by virus infection in viral-antigen-transgenic mice. Cell 65, 305-317 (1991).
6. Miller, J. F. Effect of thymectomy in adult mice on immunological responsiveness. Nature 208, 1337-1338 (1965).
7. Nishizuka, Y. & Sakakura, T. Thymus and reproduction: sex-linked dysgenesia of the gonad after neonatal thymectomy in mice. Science 166, 753-755 (1969). Day-3 thymectomy of non-autoimmune-prone BALB/c mice induces autoimmune disease (ovaritis).
8. + T cells.
9. Sakaguchi, S., Sakaguchi, N., Asano, M., Itoh, M. & Toda, M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor α-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J. Immunol. 155, 1151-1164 (1995).
10. Dardenne, M., Lepault, F., Bendelac, A. & Bach, J. F. Acceleration of the onset of diabetes in NOD mice by thymectomy at weaning. Eur. J. Immunol. 19, 889-895 (1989).
11. Wick, G., Kite, J. H. Jr & Witebsky, E. Spontaneous thyroiditis in the obese strain of chickens. IV. The effect of thymectomy and thymo-bursectomy on the development of the disease. J. Immunol. 104, 54-62 (1970).
12. Penhale, W. J., Farmer, A., McKenna, R. P. & Irvine, W. J. Spontaneous thyroiditis in thymectomized and irradiated Wistar rats. Clin Exp. Immunol. 15, 225-236 (1973).
13. + T cells.
14. low subset J. Exp. Med. 172, 1701-1708 (1990).
15. low T cells) induces immune-mediated colitis.
16. Lafaille, J. J., Nagashima, K., Katsuki, M. & Tonegawa, S. High incidence of spontaneous autoimmune encephalomyelitis in immunodeficent anti-myelin basic protein T-cell receptor-transgenic mice. Cell 78, 399-408 (1994).
17. Kurrer, M. O., Pakala, S. V., Hanson, H. L. & Katz, J. D. β-cell apoptosis in T-cell-mediated autoimmune diabetes. Proc. Natl Acad Sci. USA 94, 213-218 (1997).
18. + T cells in autoimmune diabetes. Nature Immunol. 2, 1117-1125 (2001).
19. Surh, C. D. & Sprent, J. Regulation of naive and memory T-cell homeostasis. Microbes Infect. 4, 51-56 (2002).
20. Jameson, S. C. Maintaining the norm: T-cell homeostasis. Nature Rev. Immunol. 2, 547-556 (2002).
21. Theofilopoulos, A. N., Dummer, W. & Kono, D. H. T-cell homeostasis and systemic autoimmunity. J. Invest. 108, 335-340 (2001).
22. Barthlott, T., Kassiotis, G. & Stockinger, B. T-cell regulation as a side effect of homeostasis and competition. J. Exp. Med. 197, 1-11 (2003).
23. + T-cell numbers. J. Immunol. 169, 4850-4860 (2002).
24. + T cells regulate the expansion of peripheral CD4 T cells through the production of IL-10. J. Immunol. 166, 3008-3018 (2001).
25. Bach, J. F. The effect of infections on susceptibility to autoimmune and allergic diseases. N. Engl. J. Med. 347, 911-920 (2002).
26. + T cells.
27. + suppressor cell and its mechanisms of action. J. Exp. Med. 171, 141-157 (1990).
28. Cobbold, S. P., Qin, S., Leong, L. Y., Martin, G. & Waidmann, H. Reprogramming the immune system for peripheral tolerance with CD4 and CD8 monoclonal antibodies. Immunol. Rev. 129, 165-201 (1992).
29. + T-cell regulation during the induction phase of the response. Eur. J. Immunol. 25, 2643-2649 (1995).
30. Onodera, K. et al. Induction of 'infectious' tolerance to MHC-incompatible cardiac allografts in CD4 monoclonal antibody-treated sensitized rat recipients. J. Immunol. 157, 1944-1950 (1996).
31. + regulatory cells? Immunity 14, 399-406 (2001).
32. Graca, L., Cobbold, S. P. & Waldmann, H. Identification of regulatory T cells in tolerated allografts. J. Exp. Med. 195, 1641-1646 (2002).
33. Qin, S. et al. 'Infectious' transplantation tolerance. Science 259, 974-977 (1993). The first demonstration of infectious tolerance in a transplantation model
34. Modigliani, Y. et al. Establishment of tissue-specific tolerance is driven by regulatory T cells selected by thymic epithelium. Eur. J. Immunol. 26, 1807-1815 (1996).
35. + T cells can prevent the onset of a spontaneous autoimmune disease, namely insulin-dependent diabetes mellitus in non-obese diabetic (NOD) mice.
36. + thymocytes expressing L-selectin mediate 'active tolerance' in the nonobese diabetic mouse. J. Immunol. 161, 2620-2628 (1998).
37. + T cells that prevent diabetes onset in nonobese diabetic mice. J. Immunol. 164, 240-247 (2000).
38. + immunoregulatory T cells that control autoimmune diabetes. Immunity. 12, 431-440 (2000).
39. Lando, Z., Teitelbaum, D. & Arnon, R. Effect of cyclophosphamide on suppressor-cell activity in mice unresponsive to EAE. J. Immunol. 123, 2156-2180 (1979).
40. Killen, J. A. & Swanborg, R. H. Regulation of experimental allergic encephalomyelitis. Part 4. Further characterization of postrecovery suppressor cells. J. Neuroimmunol. 3, 159-166 (1982).
41. Swierkosz, J. E. & Swanborg, R. H. Suppressor-cell control of unresponsiveness to experimental allergic encephalomyelitis. J. Immunol. 115, 631-633 (1975).
42. Yasunami, R. & Bach, J. F. Anti-suppressor effect of cyclophosphamide on the development of spontaneous diabetes in NOD mice. Eur. J. Immunol. 18, 481-484 (1988).
43. + regulatory T cells in the non-obese diabetic male mouse. Diabetologia 37, 337-343 (1994).
44. Billingham, R. E., Brent, L. & Medawar, P. B. Actively acquired tolerance to foreign cells. Nature 172, 603-606 (1953).
45. Miller, A., Lider, O. & Weiner, H. L. Antigen-driven bystander suppression after oral administration of antigens. J. Exp. Med. 174, 791-798 (1991). This study shows that tolerance induced by oral administration of myelin basic protein extends to other myelin antigens, providing the first demonstration of bystander suppression.
46. Weiner, H. L. et al. Oral tolerance: immunologic mechanisms and treatment of animal and human organ-specifics autoimmune diseases by oral administration of autoantigens Annu. Rev. Immunol. 12, 809-837 (1994).
47. Al-Sabbagh, A., Miller, A., Santos, L. M. & Weiner, H. L. Antigen-driven tissue-specific suppression following oral tolerance: orally administered myelin basic protein suppresses proteolipid protein-induced experimental autoimmune encephalomyelitis in the SJL mouse. Eur. J. Immunol. 24, 2104-2109 (1994).
48. Davies, J. D., Leong, L. Y., Mellor, A., Cobbold, S. P. & Waldmann, H. T-cell suppression in transplantation tolerance through linked recognition. J. Immunol. 156, 3602-3607 (1996).
49. Donckier, V. et al. Critical role of interleukin-4 in the induction of neonatal transplantation tolerance Transplantation 59, 1571-1576 (1995).
50. Larsen, C. P. et al. Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways. Nature 381, 434-438 (1996).
51. Kirk, A. D. et al. Treatment with humanized monoclonal antibody against CD154 prevents acute renal allograft rejection in nonhuman primates. Nature Med. 5, 686-693 (1999).
52. Askenase, P.W., Hayden, B. J. & Gershon, R. K. Augmentation of delayed-type hypersensitivity by doses of cyclophosphamide which do not affect antibody responses. J. Exp. Med. 141, 697-702 (1975).
53. Seydel, K. et al. Anti-CD8 abrogates effect of anti-CD4+ mediated islet allograft survival in rat model. Diabetes 40, 1430-1434 (1991).
54. Harrison, L. C., Dempsey-Collier, M., Kramer, D. R. & Takahashi, K. Aerosol insulin induces regulatory CD8 γδ T cells that prevent murine insulin-dependent diabetes J. Exp. Med. 184, 2167-2174 (1996).
55. + T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells. J. Exp. Med. 192, 1213-1222 (2000).
56. Prudhomme, G. J. & Piccirillo, C. A. The inhibitory effects of transforming growth factor-β1 (TGF-β1) in autoimmune diseases. J. Autoimmun. 14, 23-42 (2000).
57. Moore, K. W., de Waal Malefyt, R., Coffman, R. L. & O'Garra, A. Interleukin-10 and the interleukin-10 receptor. Annu. Rev. Immunol. 19, 683-765 (2001).
58. Rapoport, M. J. et al. Interleukin-4 reverses T-cell proliferative unresponsiveness and prevents the onset of diabetes in nonobese diabetic mice. J. Exp. Med. 178, 87-99 (1993).
59. Yamamoto, A. M. et al. The activity of immunoregulatory T cells mediating active tolerance is potentiated in non-obese diabetic mice by an IL-4-based retroviral gene therapy. J. Immunol. 166, 4973-4980 (2001).
60. Inobe, J. I., Chen, Y. & Weiner, H. L. In vivo administration of IL-4 induces TGF-β-producing cells and protects animals from experimental autoimmune encephalomyelitis. Ann. NY Acad. Sci. 778, 390-392 (1996).
61. Horsfall, A. C. et al. Suppression of collagen-induced arthritis by continuous administration of IL-4. J. Immunol. 159, 5687-5696 (1997).
62. Huang, T. J., MacAry, P. A., Wilke, T., Kemeny, D. M. & Chung, K. F. Inhibitory effects of endogenous and exogenous interferon-γ on bronchial hyperresponsiveness, allergic inflammation and T-helper 2 cytokines in Brown-Norway rats. Immunology 98, 280-288 (1999).
63. Bettelli, E. et al. IL-10 is critical in the regulation of autoimmune encephalomyelitis as demonstrated by studies of IL-10- and IL-4-deficient and transgenic mice. J. Immunol. 161, 3299-3306 (1998).
64. Bach, J. F. & Chatenoud, L. Tolerance to islet autoantigens and type 1 diabetes. Annu. Rev. Immunol. 19, 131-161 (2001).
65. Brocke, S. et al. Treatment of experimental encephalomyelitis with a peptide analogue of myelin basic protein. Nature 379, 343-346 (1996).
66. H2-Cell down-regulate adoptive transfer of experimental autoimmune encephalomyetis. J. Immunol. 164, 3563-3572 (2000).
67. H2 cells and suppression of autoimmune diabetes at late stages of disease is epitope dependent. J. Immunol. 163, 1178-1187 (1999).
68. Chen, Y., Kuchroo, V. K., Inobe, J., Hafler, D. A. & Weiner, H. L. Regulatory T-cell clones induced by oral tolerance: suppression of autoimmune encephalemyelitis Science 265, 1237-1240 (1994).
69. + T cells. J. Exp. Med. 183, 2669-2674 (1996).
70. Asseman, C., Mauze, S., Leach, M. W., Coffman, R. L. & Powrie, F. An essential role for interleukin-10 in the function of regulatory T cells that inhibit intestinal inflammation. J. Exp. Med. 190, 995-1004 (1999).
71. Phillips, J. M., Parish, N. M., Drage, M. & Cooke, A. Cutting edge: interactions through the IL-10 receptor regulate autoimmune diabetes. J. Immunol. 167, 6087-6091 (2001).
72. - thymocytes. J. Exp. Med. 189, 279-288 (1999).
73. + T-cell lines. J. Exp. Med. 185, 1769-1775 (1997).
74. Miller, A., Lider, O., Roberts, A. B., Sporn, M. B. & Weiner, H. L. Suppressor T cells generated by oral tolerization to myelin basic protein suppress both in vitro and in vivo immune responses by the release of transforming growth factor-β after antigen-specific triggering. Proc. Natl Acad. Sci. USA 89, 421-425 (1992).
75. Josien, R. et al. A critical role for transforming growth factor-β in donor transfusion-induced allograft tolerance. J. Clin. Invest. 102, 1920-1926 (1998).
76. + regulatory T cells prevent graft rejection: CTLA-4- and IL-10-dependent immunoregulation of alloresponses. J. Immunol. 168, 1080-1086 (2002).
77. + naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state. Int. Immunol. 10. 1969-1980 (1998).
78. + subpopulations. J. Immunol. 165, 3105-3110 (2000).
79. + thymocytes that express L-selectin protect rats from diabetes upon adoptive transfer. Eur. J. Immunol. 26, 2702-2708 (1996).
80. + regulatory T cells is mediated by cell-surface-bound transforming growth factor-β. J. Exp. Med. 194, 629-644 (2001).
81. + regulatory T cells can mediate suppressor function in the absence of transforming growth factor-β1 production and responsiveness. J. Exp. Med. 196, 237-246 (2002).
82. + regulatory T cells constitutively expressing cytotoxic T lmphocyte-associated antigen4. J. Exp. Med. 192, 303-310 (2000).
83. + regulatory cells that control intestinal inflammation. J. Exp. Med. 192, 295-302 (2000).
84. + immunoregulatory T cells: gene-expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor. Immunity 16, 311-323 (2002).
85. H2 gene transcripts. J. Immunol. 168, 1069-1079 (2002).
86. + regulatory T cells through GITR breaks immunological self-tolerance. Nature Immunol 3, 135-142 (2002).
87. Innes, J. B., Kuntz, M. M., Kim, Y. T & Weksler, M. E Induction of suppressor activity in the autologous mixed lymphocyte reaction and in cultures with concanavalin A. J. Clin. Invest. 64, 1608-1613 (1979).
88. + immunoregulatory Tcells suppress polyclonal T-cell activation in vitro by inhibiting interleukin-2 production. J. Exp. Med. 188, 287-296 (1998).
89. + suppressor T cells: more questions than answers. Nature Rev. Immunol. 2, 389-400 (2002).
90. Apostolou, I., Sarukhan, A., Klein, L. & Von Boehmer H. Origin of regulatory T cells with known specificity for antigen Nature Immunol. 3, 756-763 (2002).
91. R1 cells grown in vitro can suppress colitis in vivo.
92. Taguchi, O. & Nishizuka, Y. Autoimmune oophoritis in thymectomized mice: T-cell requirement in adoptive cell transfer. Clin. Exp. Immunol. 42, 324-331 (1980).
93. Taguchi, O. & Nishizuka, Y. Experimental autoimmune orchitis after neonatal thymectomy in the mouse. Clin. Exp. Immunol. 46, 425-434 (1981).
94. McCullagh, P. The significance of immune suppression in normal self tolerance. Immunol. Rev. 149, 127-153 (1996).
95. Seddon, B. & Mason, D. Peripheral autoantigen induces regulatory T cells that prevent autoimmunity. J. Exp. Med. 189, 877-882 (1999).
96. Hara, M. et al. IL-10 is required for regulatory T cells to mediate tolerance to alloantigens in vivo. J. Immunol. 166, 3789-3796 (2001).
97. + regulatory cells mediate dominant transplantation tolerance. J. Immunol. 168, 5558-5565 (2002).
98. Papiernik, M., de Moraes, M. L., Pontoux, C., Vasseur, F. & Penit, C. Regulatory CD4 T cells: expression of IL-2R α-chain, resistance to clonal deletion and IL-2 dependency Int. Immunol. 10, 371-378 (1998).
99. + regulatory T cells induced by an agonist self-peptide. Nature Immunol. 2, 301-306 (2001).
100. + immunoregulatory T cells. J. Exp. Med. 194, 427-438 (2001).
101. Mosmann, T. R., Cherwinski, H., Bond, M. W., Giedlin, M. A. & Coffman, R. L. Two types of murine helper T-cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J. Immunol. 136, 2348-2357 (1986).
102. Bacchetta, R. et al. High levels of interleukin-10 production in vivo are associated with tolerance in SCID patients transplanted with HLA-mismatched hematopoietic stem cells. J. Exp. Med. 179, 493-502 (1994).
103. +-like thymocytes in the NOD mouse. Eur. J. Immunol. 26, 2989-2998 (1996).
104. + T cells that promptly produce interleukin-4. Proc. Natl. Acad. Sci. USA 92, 11931-11934 (1995).
105. Wang, B., Geng, Y. B. & Wang, C. R. CD1-restricted NKT cells protect nonobese diabetic mice from developing diabetes. J. Exp. Med. 194, 313-320 (2001).
106. Lehuen, A. et al. Overexpression of natural killer T cells protects Vα14-Jα281 transgenic nonobese diabetic mice against diabetes. J. Exp. Med. 188, 1831-1839 (1998).
107. Sharif, S. et al. Activation of natural killer T cells by α-galactosylceramide treatment prevents the onset and recurrence of autoimmune type 1 diabetes. Nature Med. 7, 1057-1062 (2001).
108. Hong, S. et al. The natural killer T-cell ligand α -galactosylceramide prevents autoimmune diabetes in non-obese diabetic mice. Nature Med. 7, 1052-1056 (2001).
109. + T cells in mice conditioned with fractionated lymphoid irradiation protects against graft-versus-host disease: 'natural suppressor' cells. J. Immunol. 167, 2087-2096 (2001).
110. Peng, S. L. & Craft, J. T cells in murine lupus: propagation and regulation of disease. Mol. Biol. Rep. 23, 247-251 (1996).
111. Girardi, M. et al. Resident skin-specific γδ T cells provide local, nonredundant regulation of cutaneous inflammation. J. Exp. Med. 195, 855-867 (2002).
112. -/- mice. Science 256, 1210-1213 (1992).
113. Kumar, V. et al. Recombinant T-cell receptor molecules can prevent and reverse experimental autoimmune encephalomyelitis: dose effects and involvement of both CD4 and CD8 T cells. J. Immunol. 159, 5150-5156 (1997).